Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

After two days of Senate committee hearings, four Republicans have declined to commit to approving Robert F. Kennedy Jr., whose stance on vaccines remains a hot-button issue even after being presented ...

Cigna To Reform Prior Authorization, Provider Services In 2025 The Cigna Group will spend up to $150 million to reform its prior authorization, patient advocacy and provider services this year, CEO ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioi ...

The approval of Axsome Therapeutics’ Symbravo for migraine with or without aura came alongside the greenlight for Vertex's non-opioid treatment Journavx.

With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX stock over the recent years has been far from consistent, and has largely ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...